The mean preoperative BCVA values at baseline were 1.25±0.30 logMAR and 1.24±0.26 logMAR in eyes with and without SRF, respectively. Subgroup analysis between groups of patients with and without SRF showed that the mean BCVA in the SRF group was significantly worse than patients without SRF at the 1- and 3-month follow-up timepoints (P=0.022 and 0.029, respectively). However, there were no significant differences throughout the rest of the follow-up period (P=0.081 at 6mo, P=0.272 at 9mo, P=0.829 at 12mo, and P=0.499 at the final visit). aP<0.05.